Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer (Q43679860)

From Wikidata
Jump to navigation Jump to search
scientific article published in July 2001
edit
Language Label Description Also known as
English
Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer
scientific article published in July 2001

    Statements

    Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer (English)
    A J Barker
    K H Gibson
    W Grundy
    A A Godfrey
    J J Barlow
    M P Healy
    J R Woodburn
    S E Ashton
    B J Curry
    L Scarlett
    L Henthorn
    L Richards
    1 July 2001
    1911-1914

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit